文献速递消化内镜消化道肿瘤与早癌

喷洒与强制凝固模式内镜黏膜下剥离术治疗早期胃肿瘤:多中心随机对照试验

Spray and Forced Coagulation Mode Endoscopic Submucosal Dissection for Early Gastric Neoplasms: A Multicenter Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2025-02-12

SCM-ESD组仅用电刀完成ESD的比例显著高于FCM-ESD组(83.1% vs 13.8%,P < 0.0001),两组手术时间、R0切除率和不良事件率无显著差异。

要点

  • SCM-ESD组仅用电刀完成ESD的比例为83.1%,显著高于FCM-ESD组的13.8%(P < 0.0001)。
  • 两组手术时间(48.3分钟 vs 56.0分钟,P = 0.1071)无显著差异。
  • 两组R0切除率(100% vs 95.4%,P = 0.2442)和不良事件率(3.1% vs 6.2%,P = 0.6801)无显著差异。

核心结论

  • SCM-ESD显著提高了黏膜内早期胃肿瘤不使用止血钳完成ESD的比例。
  • SCM-ESD是一项有前景的技术,可能通过免去更换器械来简化ESD并降低成本。

研究设计与样本

  • 多中心随机对照试验(Spray-G试验),在5家日本机构开展。
  • 纳入黏膜内早期胃肿瘤患者,随机分配至SCM-ESD组或FCM-ESD组,每组65例。
  • 主要结局为仅用电刀(不使用止血钳)完成ESD。

主要发现

  • 仅用电刀完成ESD的比例SCM-ESD组为83.1%,FCM-ESD组为13.8%,SCM-ESD组显著更高(P < 0.0001)。
  • 手术时间SCM-ESD组为48.3分钟,FCM-ESD组为56.0分钟,两组无显著差异(P = 0.1071)。
  • R0切除率SCM-ESD组为100%,FCM-ESD组为95.4%,两组无显著差异(P = 0.2442)。
  • 不良事件率SCM-ESD组为3.1%,FCM-ESD组为6.2%,两组无显著差异(P = 0.6801)。

关键数值与推荐

  • 主要结局:仅用电刀完成ESD的比例SCM-ESD组83.1% vs FCM-ESD组13.8%(P < 0.0001)。
  • 手术时间:SCM-ESD组48.3分钟 vs FCM-ESD组56.0分钟(P = 0.1071)。
  • R0切除率:SCM-ESD组100% vs FCM-ESD组95.4%(P = 0.2442)。
  • 不良事件率:SCM-ESD组3.1% vs FCM-ESD组6.2%(P = 0.6801)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Controlling intraoperative bleeding during endoscopic submucosal dissection (ESD) is essential to ensure the safety and reliability of the procedure. ESD in spray coagulation mode (SCM-ESD) is expected to ensure more effective bleeding control. The aim of this study was to investigate the superiority of SCM-ESD over conventional forced coagulation mode ESD (FCM-ESD) in hemostatic ability for treating early gastric neoplasms (EGNs). METHODS: This multicenter randomized controlled trial (Spray-G Trial) was conducted at 5 Japanese institutions. Patients with intramucosal EGNs were enrolled and randomly assigned to either the SCM-ESD or FCM-ESD group. The primary outcome was ESD completion with an electrosurgical knife alone, that is, without the use of hemostatic forceps. The number and duration of hemostatic procedures using hemostatic forceps, procedure time, curability, and adverse events were also evaluated. RESULTS: Each group included 65 patients. The rate of ESD completion without using hemostatic forceps was significantly higher for SCM-ESD than for FCM-ESD (83.1% vs 13.8%, P < 0.0001). SCM-ESD and FCM-ESD did not differ significantly in procedure time (48.3 minutes vs 56.0 minutes, P = 0.1071), R0 resection (100% vs 95.4%, P = 0.2442), and rate of adverse events (3.1% vs 6.2%, P = 0.6801). DISCUSSION: SCM-ESD significantly improved ESD completion rates for intramucosal EGNs without using hemostatic forceps. SCM-ESD is a promising technique that may streamline ESD by eliminating the need to exchange devices and reducing costs (UMIN Clinical Trials Registry, Numbers: UMIN000047353).

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Esaki M, Sumida Y, Maehara K, et al. Spray and Forced Coagulation Mode Endoscopic Submucosal Dissection for Early Gastric Neoplasms: A Multicenter Randomized Controlled Trial. Am J Gastroenterol. 2025. PMID: 39933877. doi:10.14309/ajg.0000000000003360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。